🇮🇹 DINUTUXIMAB BETA in Italy

DINUTUXIMAB BETA (DINUTUXIMAB BETA) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)
  • Status: approved

DINUTUXIMAB BETA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DINUTUXIMAB BETA approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for DINUTUXIMAB BETA in Italy?

Marketing authorisation holder not available in our data.